The effect of RAAS inhibitors on acute hypoxemic respiratory failure and in-hospital mortality in the hypertensive Covid-19 patients

The effect of RAAS inhibitors on acute hypoxemic respiratory failure and in-hospital mortality in the hypertensive Covid-19 patients

Introduction We have aimed to investigate the relationship between use of angiotensin-converting-enzyme inhibitor (ACEI) or angiotensin-receptor-blocker (ARB) drugs and acute hypoxemic respiratory failure (AHRF) and in-hospital mortality in hypertensive Covid-19 patients. Material and method Consecu...

Full description

Bibliographic Details
Main Authors: Abdurrahman Akyüz, Ferhat Işık, Burhan Aslan, Murat Çap, İlyas Kaya, Özgür Atlı, Ümit İnci, Ercan Taştan, Adem Aktan, Önder Bilge, Metin Okşul, Emre Aydın, Zülküf Karahan, Derya Deniz Altıntaş, Rojhat Altındağ, Mehmet Şahin Adıyaman, Bernas Altıntaş
Format: Article
Language:English
Published: Taylor & Francis Group 2021-10-01
Series:Clinical and Experimental Hypertension
Subjects:
acei
acute hypoxemic respiratory failure
arb
covid-19 infection
hypertension
in-hospital mortality
Online Access:http://dx.doi.org/10.1080/10641963.2021.1916947

Internet

http://dx.doi.org/10.1080/10641963.2021.1916947

Similar Items